Assignee
ETHRIS GMBH
DE·18 granted patents·14 pending applications·18 citations·filing 2012–2025
Top patents by PatentIndex Score
32 records- 0188US10080804B2Conjugate with target-finding ligand and use thereofETHRIS GMBH·Filed 2016·Granted Sep 25, 2018·7 cites·17 claims
- 0284US11020487B2Compositions for introducing nucelic acid into cellsETHRIS GMBH·Filed 2015·Granted Jun 1, 2021·2 cites·15 claims
- 0384US2025041443A1Compositions for introducing rna into cellsETHRIS GMBH·Filed 2024·Application pending·0 cites
- 0482US10927383B2Cas9 mRNAsETHRIS GMBH·Filed 2017·Granted Feb 23, 2021·3 cites·10 claims
- 0579US10272161B2RNA for use in the treatment of ligament or tendon lesionsETHRIS GMBH·Filed 2015·Granted Apr 30, 2019·2 cites·10 claims
- 0679US9555122B2Conjugate with target-finding ligand and use thereofETHRIS GMBH·Filed 2014·Granted Jan 31, 2017·3 cites·24 claims
- 0775US11352638B2Minimal UTR sequencesETHRIS GMBH·Filed 2017·Granted Jun 7, 2022·1 cites·12 claims
- 0870US2025319160A1Use of ifn-lambda mrna for treating viral infectionsETHRIS GMBH·Filed 2025·Application pending·0 cites
- 0968US11981910B2Minimal UTR sequencesETHRIS GMBH·Filed 2022·Granted May 14, 2024·0 cites·16 claims
- 1067US2021095272A1Rna with a combination of unmodified and modified nucleotides for protein expressionETHRIS GMBH·Filed 2020·Application pending·0 cites
- 1165US2024181011A1Use of ifn-lambda mrna for treating viral infectionsETHRIS GMBH·Filed 2021·Application pending·0 cites
- 1264US11065346B2RNA for use in the treatment of ligament or tendon lesionsETHRIS GMBH·Filed 2019·Granted Jul 20, 2021·0 cites·9 claims
- 1364US10583195B2Conjugate with target-finding ligand and use thereofETHRIS GMBH·Filed 2018·Granted Mar 10, 2020·0 cites·17 claims
- 1462US12064484B2Compositions for introducing RNA into cellsETHRIS GMBH·Filed 2014·Granted Aug 20, 2024·0 cites·23 claims
- 1560US10745698B2RNA with a combination of unmodified and modified nucleotides for protein expressionETHRIS GMBH·Filed 2015·Granted Aug 18, 2020·0 cites·7 claims
- 1653US2024156729A1Formulations for aerosol formation and aerosols for the delivery of nucleic acidETHRIS GMBH·Filed 2022·Application pending·0 cites
- 1751US12522821B2Polyribonucleotide containing deuterated nucleotidesETHRIS GMBH·Filed 2019·Granted Jan 13, 2026·0 cites·16 claims
- 1851US2015291678A1Rna with a combination of unmodified and modified nucleotides for protein expressionETHRIS GMBH·Filed 2015·Application pending·0 cites
- 1950US2015290288A1Rna with a combination of unmodified and modified nucleotides for protein expressionETHRIS GMBH·Filed 2015·Application pending·0 cites
- 2050US2017056526A1Compositions for gastrointestinal administration of rnaETHRIS GMBH·Filed 2014·Application pending·0 cites
- 2150US2015258174A1Rna with a combination of unmodified and modified nucleotides for protein expressionETHRIS GMBH·Filed 2015·Application pending·0 cites
- 2248US2021348172A1Plasmid containing a sequence encoding an mrna with a segmented poly(a) tailETHRIS GMBH·Filed 2019·Application pending·0 cites
- 2346US11104887B2Ornithine transcarbamylase coding polyribonucleotides and formulations thereofETHRIS GMBH·Filed 2017·Granted Aug 31, 2021·0 cites·18 claims
- 2445US12465568B2Cryoprotective agents for particulate formulationsETHRIS GMBH·Filed 2019·Granted Nov 11, 2025·0 cites·19 claims
- 2544US2021316008A1Lipid-based formulations containing salts for the delivery of rnaETHRIS GMBH·Filed 2019·Application pending·0 cites
- 2641US2014243395A1Spray system for production of a matrix formed in situETHRIS GMBH·Filed 2012·Application pending·0 cites
- 2741US2022211807A1Treatment of ciliopathiesETHRIS GMBH·Filed 2020·Application pending·0 cites
- 2839US12509679B2mRNA purification by tangential flow filtrationETHRIS GMBH·Filed 2020·Granted Dec 30, 2025·0 cites·15 claims
- 2938US11136585B2UTRs increasing the translation efficiency of RNA moleculesETHRIS GMBH·Filed 2016·Granted Oct 5, 2021·0 cites·16 claims
- 3037US12263229B2Induction of osteogenesis by delivering BMP encoding RNAETHRIS GMBH·Filed 2015·Granted Apr 1, 2025·0 cites·20 claims
- 3137US2015126589A1Pulmonary Delivery of Messenger RNAETHRIS GMBH·Filed 2013·Application pending·0 cites
- 3233US11479768B2ATP-binding cassette family coding polyribonucleotides and formulations thereofETHRIS GMBH·Filed 2016·Granted Oct 25, 2022·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when ETHRIS GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →